GlassScriptPhysician profile
Dwayne P Andras
NPI 1043324684
$1,096.69
in general payments reported to CMS, 2019-2025
21 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.96 · 2022: $222 · 2023: $364 · 2024: $341 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $220.40 | 2021-2024 | Repatha |
| Abiomed | $115.03 | 2024-2025 | Impella |
| Pfizer INC. | $107.11 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $97.01 | 2023-2024 | |
| Kestra Medical Technology Services, INC. | $95.02 | 2023-2024 | Assure Wcd |
| Genzyme Corporation | $67.94 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.35 | 2022-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $42.98 | 2022 | |
| Philips North America LLC | $36.22 | 2023-2024 | (Ck4) Mcot |
| Mylan Specialty L.P. | $36.02 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.07 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $25.43 | 2022 | |
| Abbott Laboratories | $24.46 | 2023 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.70 | 2023 | Lifevest |
| Glaxosmithkline, LLC. | $22.18 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $18.82 | 2023 | Hillrom - Life 2000 Ventilation System |
| Lexicon Pharmaceuticals, INC. | $18.54 | 2023 | Inpefa |
| Kowa Pharmaceuticals America, INC. | $17.63 | 2023 | Livalo |
| Vital Connect, INC | $15.75 | 2024 | Vitalpatch Rtm |
| Grifols USA, LLC | $15.51 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.52 | 2025 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne Andras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.